DekaBank Deutsche Girozentrale
LYEL icon

DekaBank Deutsche Girozentrale’s Lyell Immunopharma LYEL Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,000
Closed -$215K – 1288
2023
Q1 		$215K Hold
5,000
– – ﹤0.01% 1170
2022
Q4 		$329K Hold
5,000
– – ﹤0.01% 1130
2022
Q3 		$749K Buy
+5,000
New +$677K ﹤0.01% 953

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

DekaBank Deutsche Girozentrale's LYEL Position: Q2 2023 in Review

DekaBank Deutsche Girozentrale sold out of Lyell Immunopharma (LYEL) in Q2 2023, closing a stake of 5,000 shares — an estimated $215K sold.

DekaBank Deutsche Girozentrale first reported a position in LYEL in Q3 2022 and held it in 3 quarters. The position peaked at $749K in Q3 2022. 99 funds tracked by Wall St. Rank hold LYEL as of Q2 2023.

  • DekaBank Deutsche Girozentrale reported no remaining Lyell Immunopharma position as of Q2 2023 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 5,000 Lyell Immunopharma shares in Q2 2023, an estimated $215K.
  • DekaBank Deutsche Girozentrale first reported a position in Lyell Immunopharma in Q3 2022 and held it in 3 quarters.
  • DekaBank Deutsche Girozentrale's Lyell Immunopharma position peaked at $749K in Q3 2022.
  • 99 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.